Etiopathogenesis of Psychoses by Karl Bechter
K. Bechter Etiopathogenesis of psychoses
60 Acta Clin Croat,  Vol. 49,  (Suppl) No. 2,  2010
ETIOPATHOGENESIS OF PSYCHOSES
Karl Bechter
Ulm University/BKH Guenzburg, Germany
1. Introduction
For a rather long period the known important ge-
netic contribution to mental illness was understood in 
a framework of a common disease common variant 
hypothesis. In this view the genes play a major role. 
But according to more stringent results this now seems 
diff erent (Uher 2009): gene environment interactions 
may be more important than previously thought, in-
volving especially environments that have periodically 
changed throughout evolution. Furthermore, a cumu-
lative eff ect of multiple pleiotropic variants of recent 
origin under mutation selection balance could account 
for the persistence of harmful and heritable mental ill-
ness despite the well known and strong reproductive 
disadvantage. Any valid hypothesis has especially to 
explain this latter aspect. Th e ‘evolution-informed-
framework-hypothesis’ does. 
2. Types of gene-environment-interaction
But what are environmental factors involved? New 
results support psychoimmunological mechanisms 
and infectious agents may be relevant. When applying 
modern CSF analytic methods, we found abnormal 
CSF in a considerable subgroup of therapy-resistant 
cases of both, aff ective and schizophrenic spectrum 
disorders, supporting or matching with the mild en-
cephalitis (ME) hypothesis in a subgroup of more than 
40% of patients (Bechter et al. 2010). Th e ME hypoth-
esis explains various psychiatric syndromes by low level 
neuroinfl ammation, which may arise dependent from 
infections. Together with developmental and genetic 
factors, via common immuninfl ammatory pathoge-
netic pathways, many diff erent infectious agents may 
contribute to or initiate an autoimmune CNS-related 
or CNS-specifi c process (Bechter 2001).
Th e fact, that most infectious agents are char-
acterized by only low pathogenicity (low number of 
diseased per number of infected) is also understand-
able in an evolutionary framework: the less aggres-
sive an agent is to its host the more likely it adapts 
and survives. Low pathogenicity seems especially 
frequent in neurotropic viruses, and CNS represents 
a bradytrophic tissue and therefore a preferred sur-
vival niche for viruses (Johnson 1982). Now there is 
an increasing number of fi ndings suggesting bacteri-
al, protozoal or viral agents, likely involved in mental 
disorders, mumps virus infection representing even 
the highest risk factor for psychoses found up to now 
(Dalman et al. 2008). Other candidates are Borna 
disease virus (Bechter 2001), endogenous retrovirus 
Herv-W (Perron and Leboyer 2009), parvovirus B19 
and persistent Adeno-associated virus 2 (Grant et al. 
2009), and a serious of others. An immuninfl am-
matory signature was found by highly sophisticated 
laboratory methods in blood monocytes in psychoses 
(Padmos et al. 2004). Th e diagnosis of neuropsychi-
atric disorders based on neuroimmunological studies, 
e.g. on blood cells by microRNA, is at the beginning 
but seems very promising (Keller et al. 2009). Shotgun 
proteome analysis of post-mortem tissue identifi ed 84 
diff erential expressed proteins, those involving the 
immune system, calcium homeostasis, cytoskeleton 
assembly and energy metabolism (Martins-de-Souza 
2009). Such fi ndings match with the ME hypothesis 
very well. Compare also the abstracts of the 10th Psy-
choimmunology Expert Meeting 2009 (free download 
available on www.psychoimmunology-experts.de.
Another key environmental factor to induce psy-
chotic illness seems cannabis (Lutz 2009), apparently 
a specifi c subgroup.
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3. Summary
Psychoimmunology is on the rise in neuropsychia-
try, though not well accepted yet in the fi eld of clinical 
psychiatry, but may be causally involved in a consid-
erable subgroup of psychoses. Completely diff ering 
etiological subgroups, e.g. neurodevelopmental, may 
nevertheless exist. Well established is neuroimmunol-
ogy in clinical neurology with well working laboratory 
methods, especially CSF investigation, yet the gold 
standard to diagnose infl ammatory CNS diseases. 
Low level CNS infl ammation detected in subgroups 
of patients with endogenous psychoses by modern 
CSF diagnostic methods (Bechter et al. 2010; Max-
einer et al. 2009) suggests, that CSF investigation 
plays an underestimated role in psychiatry, but can 
help to better understand severe or therapy-resistant 
psychiatric disorders.
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